We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+11.62%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$409M
AUM Growth
-$44.1M
Cap. Flow
-$59.6M
Cap. Flow %
-14.56%
Top 10 Hldgs %
18.06%
Holding
781
New
279
Increased
97
Reduced
120
Closed
283

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$10.8M
2
MSFT icon
Microsoft
MSFT
+$7.69M
3
TSM icon
TSMC
TSM
+$6.92M
4
ABBV icon
AbbVie
ABBV
+$6.78M
5
NKLA
Nikola Corporation Common Stock
NKLA
+$6.58M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$49.3M
2
BIIB icon
Biogen
BIIB
+$6.69M
3
ACN icon
Accenture
ACN
+$6.42M
4
TGT icon
Target
TGT
+$5.14M
5
DIS icon
Walt Disney
DIS
+$4.08M

Sector Composition

Rank Sector Weight
1 Technology 25.52%
2 Consumer Discretionary 16.31%
3 Healthcare 16%
4 Industrials 8.7%
5 Financials 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBBY
26
DELISTED
Bed Bath & Beyond Inc
BBBY
$2.64M 0.64%
+176,100
New +$2.03M
AMAT icon
27
Applied Materials
AMAT
$383B
$2.57M 0.63%
43,269
+17,000
+65% +$1.05M
FDX icon
28
FedEx
FDX
$78.4B
$2.56M 0.63%
+10,198
New +$2.04M
CL icon
29
Colgate-Palmolive
CL
$72.5B
$2.56M 0.63%
33,200
-15,600
-32% -$1.19M
DAL icon
30
Delta Air Lines
DAL
$53.4B
$2.51M 0.61%
82,200
+2,957
+4% +$85.3K
DXCM icon
31
DexCom
DXCM
$33.7B
$2.5M 0.61%
24,280
-21,600
-47% -$2.26M
WMT icon
32
Walmart Inc
WMT
$817B
$2.49M 0.61%
53,328
-68,100
-56% -$3.03M
BA icon
33
Boeing
BA
$166B
$2.36M 0.58%
+14,300
New +$2.44M
EW icon
34
Edwards Lifesciences
EW
$51.8B
$2.33M 0.57%
29,200
+9,500
+48% +$741K
KO icon
35
Coca-Cola
KO
$383B
$2.24M 0.55%
45,428
-55,467
-55% -$2.67M
DHI icon
36
D.R. Horton
DHI
$40.6B
$2.19M 0.53%
28,941
-100
-0.3% -$6.83K
ADI icon
37
Analog Devices
ADI
$181B
$2.16M 0.53%
18,500
+16,600
+874% +$1.94M
CAH icon
38
Cardinal Health
CAH
$54.7B
$2.14M 0.52%
45,500
+15,000
+49% +$770K
MXIM
39
DELISTED
Maxim Integrated Products
MXIM
$2.08M 0.51%
30,796
+18,996
+161% +$1.29M
SJM icon
40
J.M. Smucker
SJM
$14.1B
$2.08M 0.51%
18,000
+3,100
+21% +$346K
BAX icon
41
Baxter International
BAX
$13.4B
$2.07M 0.51%
+25,700
New +$2.16M
QRVO icon
42
Qorvo
QRVO
$8.49B
$2.06M 0.5%
16,000
-10,200
-39% -$1.26M
GEN icon
43
Gen Digital
GEN
$18.3B
$2.01M 0.49%
96,300
+26,200
+37% +$567K
INO icon
44
Inovio Pharmaceuticals
INO
$130M
$1.99M 0.49%
+14,267
New +$2.97M
BSX icon
45
Boston Scientific
BSX
$67.6B
$1.97M 0.48%
51,600
+9,700
+23% +$374K
EXPE icon
46
Expedia Group
EXPE
$38.3B
$1.93M 0.47%
21,083
-6,725
-24% -$605K
DDOG icon
47
Datadog
DDOG
$87.2B
$1.93M 0.47%
+18,905
New +$1.65M
JD icon
48
JD.com
JD
$38.5B
$1.92M 0.47%
24,700
-17,660
-42% -$1.23M
TER icon
49
Teradyne
TER
$58.2B
$1.8M 0.44%
22,600
-1,598
-7% -$136K
PGR icon
50
Progressive
PGR
$126B
$1.78M 0.43%
18,800
-9,900
-34% -$890K
1
2
3 4 5

Similar funds

MCM
Mork Capital Management Healdsburg, California $156M AUM 39.85% 1-Year Est. Return
MFG
Mosaic Financial Group Chicago, Illinois $156M AUM 23.77% 1-Year Est. Return
AFW
Atlantic Family Wealth Coral Gables, Florida $156M AUM 21.68% 1-Year Est. Return
ADBIC
A.D. Beadell Investment Counsel Mequon, Wisconsin $156M AUM 29.03% 1-Year Est. Return
HSM
H Squared Management New York $156M AUM
FWM
FMA Wealth Management Duxbury, Massachusetts $156M AUM 15.22% 1-Year Est. Return
PIA
Polaris Investment Advisors Framingham, Massachusetts $156M AUM
CCP
Cyrus Capital Partners New York $156M AUM 81.61% 1-Year Est. Return

Bayesian Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Bayesian Capital Management held 781 positions worth $409M, down 9.7% from $453M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Bayesian Capital Management withdrew a net $59.6M in Q3 2020, closing 283 positions and reducing 120 holdings. Its most notable exit was Biogen, an estimated $6.69M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in Apple worth $11.5M.

  • Bayesian Capital Management's largest Q3 2020 buy was Apple: 99,200 shares worth $11.5M.
  • Bayesian Capital Management added most to Microsoft in Q3 2020, an estimated $7.69M increase.
  • Bayesian Capital Management's biggest Q3 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $49.3M.
  • Bayesian Capital Management fully exited Biogen in Q3 2020, selling an estimated $6.69M.
  • Bayesian Capital Management's ten largest holdings make up 18% of its $409M portfolio in Q3 2020.
  • Bayesian Capital Management opened 279 new positions and closed 283 in Q3 2020.
  • Bayesian Capital Management's portfolio value fell 9.7% quarter-over-quarter to $409M.

Based on Bayesian Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.